Zobrazeno 1 - 10
of 12
pro vyhledávání: '"Andrew M. Blum"'
Publikováno v:
Neurology and Therapy, Vol 13, Iss 6, Pp 1535-1540 (2024)
Externí odkaz:
https://doaj.org/article/57a0877348da4184b7ff7d0b17021a4c
Autor:
Andrew M. Blumenfeld, Laszlo Mechtler, Lisa Cook, Christopher Rhyne, Brian Jenkins, Olivia Hughes, Brett Dabruzzo, Aubrey Manack Adams, Merle Diamond
Publikováno v:
Pain and Therapy, Vol 13, Iss 6, Pp 1571-1587 (2024)
Abstract Introduction Combination use of atogepant and onabotulinumtoxinA has the potential to be more effective than either alone for the preventive treatment of chronic migraine (CM) due to their complementary mechanisms of action. This analysis co
Externí odkaz:
https://doaj.org/article/9bb21333a6b9477695cc5d48969da9f6
Autor:
Andrew M. Blumenfeld, Richard B. Lipton, Stephen Silberstein, Stewart J. Tepper, Larry Charleston, Stephen Landy, Deena E. Kuruvilla, Aubrey Manack Adams
Publikováno v:
Neurology and Therapy, Vol 12, Iss 5, Pp 1533-1551 (2023)
Abstract Migraine is a neurologic disease with a complex pathophysiology that can be controlled with current treatment options but not cured. Therefore, treatment expectations are highly variable. The concept of migraine freedom was recently introduc
Externí odkaz:
https://doaj.org/article/bb3f6e1700ef433e92ce463429385b39
Autor:
Andrew M. Blumenfeld, James P. Boyd
Publikováno v:
BMC Neurology, Vol 22, Iss 1, Pp 1-9 (2022)
Abstract Objective To assess the nocioceptive input of habitual nocturnal jaw clenching that acts as a contributing factor in migraine pathogenesis. Background Habitual nocturnal jaw clenching has been implicated as a trigger, particularly in those w
Externí odkaz:
https://doaj.org/article/af287a66c88145f48bd811231cd2fdd6
Autor:
Melissa Estrella, Christopher A. Teleha, Gary A. Cain, Alfred J. Mical, Andrew M. Blum, Edd R. Holler, James S. Piecara, George C. Emmett, Dean A. Wacker
Publikováno v:
Synthesis. 2005:92-96
Methods for the preparation of (3S)-3-(4-fluorobenzyl)piperidine (2) and its mandelate salt (9) are described. The first generation synthesis started from 3-benzylpiperidone, and required Boc protection of the nitrogen for efficient separation of the
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::32a41940b9728638926eda6d6cec68db
https://doi.org/10.1055/s-2004-834903
https://doi.org/10.1055/s-2004-834903
Publikováno v:
Chirality. 6:302-313
Good results have been obtained with use of the new bonded chiral stationary phase Whelk-O 1 in analytical and preparative subcritical fluid chromatography. A wide variety of enantiomeric pairs of compounds with different functional groups that are o
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::2b4b62a83538f47b5b89675c3ac7714b
https://doi.org/10.1002/chir.530060414
https://doi.org/10.1002/chir.530060414
Autor:
David B. Clemow, Kirk W. Johnson, Helen M. Hochstetler, Michael H. Ossipov, Ann M. Hake, Andrew M. Blumenfeld
Publikováno v:
The Journal of Headache and Pain, Vol 21, Iss 1, Pp 1-13 (2020)
Abstract Migraine is a leading cause of disability worldwide, but it is still underdiagnosed and undertreated. Research on the pathophysiology of this neurological disease led to the discovery that calcitonin gene-related peptide (CGRP) is a key neur
Externí odkaz:
https://doaj.org/article/2862c682cbcd488db55c7f0c23bb485b
Autor:
William B. Young, J. Ivan Lopez, John F. Rothrock, Amelia Orejudos, Aubrey Manack Adams, Richard B. Lipton, Andrew M. Blumenfeld
Publikováno v:
The Journal of Headache and Pain, Vol 20, Iss 1, Pp 1-10 (2019)
Abstract Background OnabotulinumtoxinA is effective in preventing chronic migraine (CM); however, the benefit of onabotulinumtoxinA in patients with CM with daily headache is unknown because these patients are typically excluded from clinical trials.
Externí odkaz:
https://doaj.org/article/fe8740504e1e4f8da398ab5cc3ea9155
Autor:
William B. Young, J. Ivan Lopez, John F. Rothrock, Amelia Orejudos, Aubrey Manack Adams, Richard B. Lipton, Andrew M. Blumenfeld
Publikováno v:
The Journal of Headache and Pain, Vol 20, Iss 1, Pp 1-10 (2019)
Abstract Background OnabotulinumtoxinA is effective in treating chronic migraine (CM), but there are limited data assessing how allodynia affects preventive treatment responses. This subanalysis of the 108-week, multicenter, open-label COMPEL Study a
Externí odkaz:
https://doaj.org/article/34919c94b35746dba55267f019599f2b
Autor:
Andrew M. Blumenfeld, Atul T. Patel, Ira M. Turner, Kathleen B. Mullin, Aubrey Manack Adams, John F. Rothrock
Publikováno v:
Journal of Primary Care & Community Health, Vol 11 (2020)
Introduction/Objective: Chronic migraine (CM) is associated with impaired health-related quality of life and substantial socioeconomic burden, but many people with CM are underdiagnosed and do not receive appropriate preventive treatment. Onabotulinu
Externí odkaz:
https://doaj.org/article/b03d6ce85948495295e184bae23bfbf3